IN BRIEF (Page 17)

J&J rises

Johnson & Johnson's profit rose 14 percent as job reductions and rising sales of consumer products such as Listerine and Tylenol helped the world's largest maker of healthcare products withstand the global recession.

Fourth quarter net income climbed to $2.71 billion, or 97 cents a share, from $2.37 billion, or 82 cents, a year earlier, the New Brunswick, New Jersey-based company said.